Editor-in-Chief

info@partnersindigitalhealth.com

John D. Halamka, MD, MS,  International Healthcare Innovation Professor, Harvard Medical School, USA

Competing interests and/or Financial disclosure

Blockchain in Healthcare Today requires all board and staff members to disclose relevant financial relationships.  An individual has a relevant financial relationship if he/she and/or a spouse or partner had a financial relationship in any amount occurring in the last 12 months with a commercial interest. As such, the following interests are declared below.

Commercial interests:

  1. Arcadia Healthcare Solutions Advisory Board
  2. New Leaf Venture Partners Advisory Board
  3. Orion Healthcare Board of Directors
  4. Gates Foundation Consultant

 

Douglas Shinsato, Editor Emeritus 

 

Editorial Stewards

Combiz Richard Abdolrahimi, Emerging Technologies & Innovation Leader, Deloitte, USA

Competing interests and/or Financial disclosure

I have no commercial interests to declare.

 

Gil Alterovitz, PhD, Faculty, Harvard Medical School/Boston Children's Hospital, Massachusetts Institute of Technology, USA

Competing interests and/or Financial disclosure

I have no commercial interests to declare.

 

Mate Beštek, BSc, National Institute of Public Health, Center for Healthcare Informatics, Republic of Slovenia; Faculty, Computer and Information Dept., University of Ljubljana, Slovenia

Competing interests and/or Financial disclosure

I am Advisor to Iryo.io

 

Uli Broedl, MD, VP Medical & Regulatory Affairs, Boehringer Ingelheim Canada

Competing interests and/or Financial disclosure

I work for Boehringer Ingelheim

 

Kevin A. Clauson, PharmD, Associate Professor, Lipscomb University College of Pharmacy & Health Sciences, USA

Competing interests and/or Financial disclosure

I have served as a consultant through a third party consultancy for blockchain companies focused on healthcare and health care companies exploring blockchain solutions. I have fluid cryptoasset/cryptocurrency holdings.

 

Nitin Gaur, Director, IBM WW Digital Asset Labs at IBM, USA

Competing interests and/or Financial disclosure

I have no commercial interests to declare.

 

Florence D. Hudson, Founder and CEO, FDHint, Special Advisor of NSF Cybersecurity Center of Excellence at Indiana University, Northeast Big Data Innovation Hub at Columbia University, IEEE Engineering in Medicine and Biology Society - Standards Committee, USA

Competing interests and/or Financial disclosure

I have no commercial interests to declare.

 

Mike Jacobs, Technology Fellow and SVP of Engineering, Optum, USA

 Competing interests and/or Financial disclosure

  1. Employee of Optum (part of Unitedhealth Group)
  2. Stock shareholder of Unitedhealth Group (UNH)
  3. Holder of intellectual property rights and patents

 

Taha Kass-Hout, MD, MS, Former FDA Chief Health Informatics Officer, USA

Competing interests and/or Financial disclosure

I have no commercial interests to declare.

 

George Kolostoumpis, BSc, PhD, External Scientific Expert, ECDC; Technical Expert, EUREKA, Greece

Competing interests and/or Financial disclosure

I have no commercial interests to declare.

 

Prasad Kothari, MS, Vice President - The Smart Cube, USA

Competing interests and/or Financial disclosure

I have no commercial interests to declare.

 

Tim Ken Mackey, MAS, PhD, Associate Professor of Anesthesiology and Global Public Health, UC San Diego School of Medicine and Director of Healthcare Research and Policy, UC San Diego, USA

Competing interests and/or Financial disclosure

Tim K. Mackey serves as the Co-Chair for the IEEE Standards Association Supply Chain/Clinical Trials Technology Implementation Industry Connections Program, is an invited participant in the DSCSA & Blockchain Study by the Center for Supply Chain Studies, and is a member of the Advisory Board for the company FarmaTrust, a blockchain company developing technology for the pharmaceutical supply chain.

 

Manouchehr (Mitch) Mokhtari, PhD, Professor, School of Public Health, University of Maryland, College Park, USA

Competing interests and/or Financial disclosure

I have no commercial interests to declare.

 

Jim Markwith, Founder, Markwith Law PS, Faculty and Mentor, Santa Clara University School of Law, Entrepreneurs' Law Clinic, USA

Competing interests and/or Financial disclosure

In my capacity as a technology, IT, and healthcare IT attorney, I am outside legal counsel to multiple healthcare related entities. 

  1. Apervita, Inc.
  2. Blue Cross Blue Shield of South Carolina
  3. Blue Health Intelligence
  4. CommonWell Health Alliance, Inc.
  5. Discover Alliance, Inc.
  6. Eligible, Inc.
  7. Health Data Link, Inc.
  8. Stryker Corporation

 

Jim NasrVice President, Technology & Innovation, Synchrogenix, a Certara company, USA

Competing interests and/or Financial disclosure
I am an employee of Certara - a privately owned organization providing software and services to the life sciences and healthcare industry. I hold a limited range of cryptoassets.

 

Susan Ramonat, CEO, Spiritus Partners, USA

Competing interests and/or Financial disclosure
I am a shareholder and board member of Spiritus Partners, Inc.

 

Erik Pupo, Chief Information Officer, Columbia University Irving Medical Center, USA

Competing interests and/or Financial disclosure

TBD

 

Mona Siddiqui, MDMPH, Chief Data Officer, Department of Health and Human Services (HHS), USA

Competing interests and/or Financial disclosure

I have no commercial interests to declare.

 

Tom Savel, MD, Director, Informatics Innovation Unit, Center for Surveillance, Epidemiology and Laboratory Services, Centers for Disease Control and Prevention (CDC), USA

Competing interests and/or Financial disclosure

I have fluid cryptoasset/cryptocurrency holdings.

 

Peer Reviewers

Debbie Bucci, IT Architect, USA

Competing interests and/or Financial disclosure

I have no commercial interests to declare.

 

Bill Buchanan, OBE, Professor, School of Computing, Edinburgh Napier University; Fellow, BCS and IET, United Kingdom

Competing interests and/or Financial disclosure

I have no commercial interests to disclose.

 

Vikram Dhillon, Research Fellow, Institute of Simulation and Training at University of Central Florida, USA

Competing interests and/or Financial disclosure

I have no commercial interests to declare.

 

Cees Hesp, Director mHealth Research Labs, PharmAccess Foundation, and Director, Digital Impact Alliance (DIAL), United Nations Foundation, Netherlands

Competing interests and/or Financial disclosure

I am employed at PharmAccess, serve on the board of Directors of DIAL, and have an unpaid advisory role at SuretyBlock. SuretyBlock is a blockchain-based online insurance marketplace. I have no other commercial interests to disclose.

 

Louis O. Jeansonne IV, MD, Assistant Vice President for Medical Affairs, Ochsner Medical Center Baton Rouge, USA

Competing interests and/or Financial disclosure

I have no commercial interests to declare.

 

Anh L. Ngo, MD, MBA, Co-Founder, Pain Specialty Group, Committee on Admissions, Harvard Medical School, USA

Competing interests and/or Financial disclosure

I am the owner of Safety Medical Laboratories (safemedlabs.com)

 

Tina Penman, AuD, Regional Research Administrator, Department of Defense Hearing Center of Excellence (HCE), National Center for Rehabilitative Auditory Research (NCRAR), VA Portland Health Care System, USA

Competing interests and/or Financial disclosure

I have no commercial interests to declare.

 

Dennis Porto MD, MPH, FAAD, is the Lewis Wendell Hackett award recipient at Harvard where he contributes to the blockchain and bitcoin curriculum at Harvard Business School, USA

Competing interests and/or Financial disclosure

I have equity or agreements for future equity investments in several private companies to be disclosed upon request. I have equity investments in the following public companies: Google, Netflix, Amazon, and Facebook. I am an investor in artificial intelligence, robotics, and biotech exchange-traded funds. I own bitcoin. I am a peer-reviewer for JAMA Dermatology and the Journal of Cosmetic dermatology. I am an editor of the textbook Botulinum Toxins in Dermatology and do not receive royalty.

 

Karl A. Poterack, MD, Medical Director, Applied Clinical Informatics, Mayo Clinic, Associate Medical Information Officer, Mayo Clinic Arizona and Assistant Professor of Anesthesiology, Mayo Clinic College of Medicine, USA

Competing interests and/or Financial disclosure

I have no commercial interests to declare.

 

Ana Santos Rutschman, Assistant Professor of Law, Center for Health Law Studies, Saint Louis University School of Law, USA

Competing interests and/or Financial disclosure

I have no commercial interests to declare.

 

Amanda Stanhaus is a Health Management and Policy Ph.D. student at The University of Michigan. Formerly,  J.P.Morgan’s Blockchain strategist for Quorum, USA

Competing interests and/or Financial disclosure

I have no commercial interests to declare.

 

Jin Wei-Kocsis, Ph.D., Assistant Professor in Computer & Information Technology, Purdue University, USA

Competing interests and/or Financial disclosure

I have no commercial interests to declare.

 

Publishing and Operations Staff

Tory Cenaj
Founder, Owner, and Publisher, Partners in Digital Health, USA

t.cenaj@partnersindigitalhealth.com
info@partnersindigitalhealth.com

Competing interests and/or Financial disclosure

I am the founder and owner of Partners in Digital Health, including the journals Blockchain in Healthcare Today, Telehealth and Medicine Today, all related activities and initiatives associated with these titles, and company portfolio. I volunteer for, and own, SolarCoin.

 

John Russo Jr., PharmD, Managing Editor, USA

j.russo@partnersindigitalhealth.com

info@partnersindigitalhealth.com

Competing interests and/or Financial disclosure

I am the owner of The MedCom Resource.

 

Ron Ribitzky MD, Marketing & UX Strategy Advisor, USA

info@partnersindigitalhealth.com

Competing interests and/or Financial disclosure

Stock shareholder of iSpecimen. Business Partner of DEMTECH.biz, East-West Digital News, ACTIMIRA., and TALENTGRID VENTURES.  Strategic Advisor and token rights holder ARNA Genomics, BitMED. MarketsandMarkets Honorarium recipient.  Komodo Health